TCM
TECH icon

Twin Capital Management’s Bio-Techne TECH Stock Holding History

Twin Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-39,240
Closed -$929K – 307
2013
Q4 		$929K Buy
+39,240
New +$850K 0.1% 225

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Twin Capital Management's TECH Position: Q1 2014 in Review

Twin Capital Management sold out of Bio-Techne (TECH) in Q1 2014, closing a stake of 39,240 shares — an estimated $929K sold.

Twin Capital Management first reported a position in TECH in Q4 2013 and held it in 1 quarter. The position peaked at $929K in Q4 2013. 240 funds tracked by Wall St. Rank hold TECH as of Q1 2014.

  • Twin Capital Management reported no remaining Bio-Techne position as of Q1 2014 after selling out during the quarter.
  • Twin Capital Management sold 39,240 Bio-Techne shares in Q1 2014, an estimated $929K.
  • Twin Capital Management first reported a position in Bio-Techne in Q4 2013 and held it in 1 quarter.
  • Twin Capital Management's Bio-Techne position peaked at $929K in Q4 2013.
  • 240 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2014.

Based on Twin Capital Management's 13F filing for Q1 2014, filed 13 May 2014.